Navigation Links
New stem cell research could reduce number of animal experiments
Date:8/4/2009

Researchers from the University of Bath are embarking on a project to use stem cell technology that could reduce the number of animal experiments used to study conditions such as motor neurone disease.

Dr Vasanta Subramanian, from the University's Department of Biology & Biochemistry, will be developing a technique using human stem cells to study this debilitating neurological disease, greatly reducing the number of animals used in research.

Stem cells are the precursor cells that are able to develop into more specialised cells and tissues such as neurones or skin cells.

Whilst previously most stem cells were derived from embryos, this new research project will instead use Induced Pluripotent Stem cells (iPS cells) which are made from skin cells from adults.

Dr Subramanian has been awarded a major three year grant by the National Centre for Replacement, Refinement & Reduction of Animals in Research (NC3Rs) to study ALS, a form of motor neurone disease in which the nerve cells that control the muscles die.

This currently incurable condition causes patients to lose movement in muscles, affecting breathing and eventually causing death.

Dr Subramanian will be making iPS cells from the skin cells of patients suffering from ALS to study the genes that are thought to cause the disease.

She said: "These are exciting times for stem cell research and there is tremendous potential in the iPS cell technology both for medical applications and in basic biology.

"This technology will not only help understand the mechanisms underlying the disease, but will also reduce the numbers of animals used in research.

"There is a real need to develop alternative methods for studying these diseases that are more robust and better simulate how the disease develops in humans."

The grant will fund a teaching replacement for Dr Subramanian, allowing her to focus on her research, and a research assi
'/>"/>

Contact: Vicky Just
v.j.just@bath.ac.uk
44-122-538-6883
University of Bath
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Research shows skeleton to be endocrine organ
2. Newly created cancer stem cells could aid breast cancer research
3. Dominant cholesterol-metabolism ideas challenged by new research
4. Researchers identify proteins involved in new neurodegenerative syndrome
5. Texas researchers and educators head for Antarctica
6. MGH researchers describe new way to identify, evolve novel enzymes
7. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
8. University of Oregon researcher finds that on waters surface, nitric acid is not so tough
9. U of MN researchers discover noninvasive diagnostic tool for brain diseases
10. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
11. Story ideas from the Journal of Lipid Research

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New stem cell research could reduce number of animal experiments
New stem cell research could reduce number of animal experiments
(Date:11/23/2009)...alifornia biomedical engineer and cardiologist Tzu...p clinicians distinguish cardiac emergencies requi...eable with drugs and lifestyle change. , Angiogr...teries feeding the heart, offer an inside view of ...els, often revealing deposits of a dangerous fatty...
(Date:11/23/2009)...General Medical Sciences (NIGMS), part of the Nati...3 million for grants in scientific areas it identi...the GO grant program to stimulate biomedical resea...erican Recovery and Reinvestment Act (Recovery Act...o have a significant impact on a field of biomedic...
(Date:11/23/2009)... is Director of the Interuniversity Professorship ...and the University of the Basque Country. The Prof...as other experts such as researchers in the fields...ts in ethics. , The Interuniversity Professorshi... of Deusto and the Basque Country was created in 1...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2A tiny frozen microbe may hold clues to extraterrestrial life 8822 1A tiny frozen microbe may hold clues to extraterrestrial life 8822 2Advance in understanding cellulose synthesis 8820 1Advance in understanding cellulose synthesis 8820 2Advance in understanding cellulose synthesis 8820 3Keep Safety in Mind While Cooling Off in the Water 48824 1Keep Safety in Mind While Cooling Off in the Water 48824 2
... Four hundred researchers tapping the massive flow...30 to share their recent developments at the 2nd A...tute (DOE JGI) User Meeting. DOE JGI is the world,...ughput DNA sequencing available to a diverse resea...erwise would not have access to such a resource to...
... A team of Canadian researchers, lead by Dr. Susan...iction and Mental health (CAMH), discovered a dist...mposed of two different types of dopamine receptor...n understanding and treating schizophrenia. , Publ...f Sciences USA (Rashid et al., 2007), this importa...
... Some day, heart attack survivors might have a pat...t, to replace areas that died during their attack....et new ones that can grow in place, rather than be...ged or weak blood vessels might get a new “natural...se possibilities are all within reach, and could t...
Other Biology News:New dopamine brain target discovered 2Engineering the heart piece by piece 2Engineering the heart piece by piece 3Engineering the heart piece by piece 4
(Date:11/24/2009)..., ST.LOUIS,Nov.24/PRNewswire-FirstCall/--Sigma-Ald...eNASDAQOMXconferenceonTuesday,December1stat1:45PMG...vialiveaudiobroadcastovertheInternetavailableat h...rscanclickthe"Webcast"icontoaccessthisfile. ,, ...ScienceandHighTechnologycompany.Itschemicalandbioc...
(Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Ne...anyfocusedondevelopingandcommercializingnovelpainm...o,PresidentandChiefExecutiveOfficer,isscheduledtop...nce,tobeheldDecember1-2,2009atTheNewYorkPalaceHote...lieri,ChiefFinancialOfficer,willbeavailabletorespo...
(Date:11/24/2009)... ,Primaryefficacyendpointhasbeenmetforpatientswith..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZ...globalbiopharmaceuticalcompanyfocusedonendocrineth...afromaPhase2studywithitstargetedcytotoxicpeptideco...ancedorrecurrentendometrialcancer.Inapersonalizedh...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/-...atRandyScott,GenomicHealth,sExecutiveChairman,will...enceinNewYorkCityonTuesday,December1,2009at10:00a....webcastofthepresentation,visittheInvestorRelations...genomichealth.com .Pleaseconnecttothewebsiteatleas...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...apeutics,Inc. (MTI), a company that discovers and ...gs, announces that it has retained Marquant Partne...se on its strategic and partnering,opportunities, ...lders., This appointment follows a significant am...financial and pharmaceutical companies after its,a...
...a-,Aldrich Corporation announced today that it wil...dnesday, March 19, 2008 at its Life Science & High...uis, Mo. 63103, The event will begin at 8:30 a.m....be webcast over the Sigma-Aldrich website at, http...Sigma-Aldrich is a leading Life Science and High,T...
...Deliver Electronic X-ray-Based, Therapy Directly ...tings, SUNNYVALE, Calif., March 17 Xoft, Inc., t...ance from the U.S. Food & Drug,Administration (FDA...m, a,proprietary technology platform designed to d...iation treatment in minimally-shielded,clinical se...
Other Biology Technology:Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 2Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities 3FDA Clears Expanded Use of Xoft's Axxent(R) Electronic Brachytherapy System for all Radiation Therapy Indications 2
Mouse Anti-DNA-PKcs, phospho (Thr2609) Monoclonal Antibody, Unconjugated, Clone 10B1 from BioLegend
Rabbit Anti-Histamine H2 Receptor Polyclonal Antibody, Unconjugated from IMGENEX
NF kappa B Related Sampler Kit from BD Biosciences Pharmingen
Glycogen Coprecipitant from Bioline
Biology Products: